Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CoMFA-SIMCA model for antichagasic nitrofurazone derivatives.

V Martinez-Merino1, H Cerecetto

  • 1Departamento de Química Aplicada, Universidad Pública de Navarra, Pamplona, Spain. merino@unavarra.es

Bioorganic & Medicinal Chemistry
|May 17, 2001
PubMed
Summary

Novel nitrofurazone derivatives demonstrated significant trypanocidal activity against Trypanosoma cruzi. These compounds, particularly those with specific N4 substituents, offer promising leads for developing new drugs to combat Chagas disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of 3D-QSAR and pharmacophoric models to design new anti-<i>Trypanosoma cruzi</i> agents based on 2-aryloxynaphthoquinone scaffold.

SAR and QSAR in environmental research·2022
Same author

Synthesis and evaluation of new heteroaryl nitrones with spin trap properties.

RSC advances·2022
Same author

Morphological and Biochemical Characterization of a Cell Death Process Induced by E3, a New Synthetic Diarylsulfonilurea Analogue.

TheScientificWorldJournal·2018
Same author

Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.

Journal of labelled compounds & radiopharmaceuticals·2014
Same author

o-Nitroanilines as major metabolic products of anti-Trypanosoma cruzi 5-phenylethenylbenzofuroxans in microsomal and cytosolic fractions of rat hepatocytes and in whole parasitic cells.

Xenobiotica; the fate of foreign compounds in biological systems·2009
Same author

Insight into the bioreductive mode of action of antitrypanosomal 5-nitrofuryl containing thiosemicarbazones.

Medicinal chemistry (Shariqah (United Arab Emirates))·2008

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Computational Chemistry

Background:

  • Trypanosoma cruzi causes Chagas disease, a neglected tropical illness.
  • Existing treatments for Chagas disease have limitations, necessitating new drug development.
  • Nitrofurazone derivatives and thiophene analogues are explored for their antiparasitic potential.

Purpose of the Study:

  • To correlate physico-chemical properties of nitrofurazones and thiophene analogues with their trypanocidal activity.
  • To develop 3D-QSAR models for predicting activity against Trypanosoma cruzi.
  • To identify structural features essential for in vitro and in vivo efficacy.

Main Methods:

  • Synthesis and characterization of 5-nitro-2-furaldehyde semicarbazones and thiophene analogues.

Related Experiment Videos

  • In vitro and in vivo testing of compounds against Trypanosoma cruzi (Tulahuen strain).
  • Quantitative Structure-Activity Relationship (QSAR) analysis using SIMCA and CoMFA methodologies.

    • Main Results:

    • Nitrofurazones with specific N4 substituents (14-17 Å range, ~6 Å thickness) achieved complete survival in infected mice.
    • In vitro models permitted larger N4 substituents than survival models, with restrictions on positive centers.
    • QSAR models indicated an active site interaction with trypanothione reductase (TR).

    Conclusions:

    • Structural modifications, particularly N4 substituents, significantly impact trypanocidal activity.
    • Developed QSAR models can guide the design of novel anti-Trypanosoma cruzi agents.
    • Future drug design should focus on amide-like groups near easily reducible moieties for optimal efficacy.